Jürg Tschopp (born 1951 in Basel — died 22 March 2011 in the Swiss Alps) was a Swiss biochemist, known for his research on apoptosis and the immunology of inflammation.[1] His greatest achievement was perhaps his team's discovery and scientific description of the inflammasome (which he named).[2]
Equipped with a formidable fresh practical knowledge of protein biochemistry, Jürg Tschopp readily identified perforin, the major lytic protein in the granules, and a whole family of proteases, the so-called granzymes ... It is now well established that granzymes, together with perforin, are required for the efficient lysis of the cells targeted by CTLs, such as virally infected cells or transformed tumor cells. He spearheaded the efforts to generate perforin-deficient mice in the early 1990s, a time when knockout technology was still a major endeavor. These mice revealed that CTLs could resort to a second lytic pathway initiated by Fas ligand (FasL), a now well-established apoptosis-inducing ligand ...[3]
He and his colleagues discovered "viral and mammalian forms of the caspase-8-related protein FLIP" (FLICE-Like Inhibitory Protein, where "FLICE" is an alias for caspase-8). They elucidated the molecular mechanisms of caspase-8's involvement in cell death processes and in nonapoptotic signalling pathways.[2] In 2000 he with 9 co-workers published their discovery "that, similar to apoptosis, caspase-independent cell death (necroptosis) was a tightly controlled cell biological process that was dependent on the kinaseRIP1."[3]
He was involved in the discovery of B-cell activating factor (BAFF), also known as B Lymphocyte Stimulator (BLyS), a cytokine that stimulates the reproduction of B cells. This led to the development of a new drug, Belimumab, approved by the FDA in 2011 for systemic lupus erythematosus.[5]
Tschopp's group, and other groups, established that mutations in the gene for the protein NLRP3, also known as cryopyrin, (one of the proteins forming the inflammasome) cause cryopyrin-associated periodic syndrome (CAPS), which is a group of rare autoimmune disorders. Patients with CAPS are "now successfully treated with IL-1 antagonists such as anakinra or blocking antibodies."[3]
In 2005, Tschopp with six colleagues described the function of a "novel cytoplasmic protein complex" involving what is now known as Mitochondrial Antiviral-signaling protein (MAVS), also known as CARDIF or Cardif. The "novel cytoplasmic protein complex ... detects RNA and ... is essential for sensing most intracellular viruses. This complex consists of RIG-I and CARDIF and triggers a robust type I interferon response. His group demonstrated that CARDIF is proteolytically cleaved and inactivated by HCV, thereby explaining the persistence of this viral infection ..."[3]
In 2006 Tschopp with 4 colleagues "showed that gout-associated monosodium urate crystals and pseudogout-associated pyrophosphate dihydrate crystals can stimulate activation of the NLRP3 inflammasome, ... establishing the pathophysiological bases of gout (or pseudogout)-associated inflammatory reactions."[6]
He died of a heart attack on a ski trip with his son in the Swiss Alps.[3] In his youth he was nationally ranked in the decathlon and was later active in hiking, running, and skiing.[2]
Tschopp, J.; Müller-Eberhard, H. J.; Podack, E. R. (1982). "Formation of transmembrane tubules by spontaneous polymerization of the hydrophilic complement protein C9". Nature. 298 (5874): 534–538. Bibcode:1982Natur.298..534T. doi:10.1038/298534a0. PMID7099251. S2CID4310786.
Tschopp, J.; Masson, D.; Stanley, K. K. (1986). "Structural/Functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis". Nature. 322 (6082): 831–834. Bibcode:1986Natur.322..831T. doi:10.1038/322831a0. PMID2427956. S2CID4330219.
Hahne, M.; Rimoldi, D.; Schröter, M.; Romero, P.; Schreier, M.; French, L. E.; Schneider, P.; Bornand, T.; Fontana, A.; Lienard, D.; Cerottini, J.; Tschopp, J. (1996). "Melanoma cell expression of Fas(Apo-1/CD95) ligand: Implications for tumor immune escape". Science. 274 (5291): 1363–1366. Bibcode:1996Sci...274.1363H. doi:10.1126/science.274.5291.1363. PMID8910274. S2CID24139146.
